Geode Capital Management, LLC Titan Pharmaceuticals Inc Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.45 - $0.66 $10,791 - $15,826	23,980 Added 37.49%	87,945 $41,000
Q4 2022 Feb 13, 2023	SELL	$0.77 - $22.8 $97 - $2,895	-127 Reduced 0.2%	63,965 $50,000
Q3 2022 Nov 14, 2022	BUY	$0.53 - $22.6 $921 - $39,301	1,739 Added 2.79%	64,092 $69,000
Q2 2022 Aug 12, 2022	BUY	$0.38 - $0.94 $3,534 - $8,742	9,300 Added 17.53%	62,353 $34,000
Q4 2021 Feb 11, 2022	SELL	$1.02 - $1.93 $44 - $84	-44 Reduced 0.08%	53,053 $54,000
Q2 2021 Aug 13, 2021	BUY	$2.24 - $2.9 $39,383 - $50,987	17,582 Added 49.51%	53,097 $138,000
Q1 2021 May 12, 2021	BUY	$2.66 - $4.23 $2 - $4	1 Added 0.0%	35,515 $105,000
Q4 2020 Feb 12, 2021	BUY	$3.0 - $6.0 $106,542 - $213,084	35,514 New	35,514 $116,000

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $58.5M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.